Newark, DE
QPS, a leading GLP/GCP‑compliant contract research organization providing testing services to support preclinical and clinical research and development, announced today that QPS Taiwan, its Asian operation, has been awarded a Good Laboratory Practice (GLP)‑laboratory certification by the Department of Health (DOH), Executive Yuan, R.O.C. (Taiwan). QPS received this certification due to their exceptional track record and scientific infrastructure, including global Standard Operating Procedures (SOPs), understanding of the regulatory agency of requirement, and planning for the implementation of systems and processes within the Taiwan facility.
“QPS Taiwan has been awarded the first and only GLP-laboratory certification by DOH, Taiwan for bioanalytical services supporting preclinical and clinical research,” stated QPS Taiwan President and CEO, Vincent Yen, M.B.A. “QPS Taiwan shares the same criteria, global SOPs, laboratory procedures, equipment (API 4000 triple quadrupole mass spectrometers, Shimadzu VP-series LCs, Tomtec Quadra), laboratory operations (Rees Monitors, Watson LIMS systems), and systems and processes as QPS U.S.A. We are excited about this certification..."
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.